{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:20:17Z","timestamp":1792819217287,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council of Taiwan","doi-asserted-by":"crossref","award":["111-2314-B-002-138"],"award-info":[{"award-number":["111-2314-B-002-138"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00259-025-07399-5","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T23:19:21Z","timestamp":1749770361000},"page":"192-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["[68Ga]Ga-DOTA-TOC positron emission tomography outperforms [18F]FDOPA and [18F]FDG PET in pediatric neuroblastoma imaging: a prospective study"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1641-5617","authenticated-orcid":false,"given":"Chia-Ju","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-9621","authenticated-orcid":false,"given":"Kuan-Yin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4461-9967","authenticated-orcid":false,"given":"Meng-Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-0124","authenticated-orcid":false,"given":"Wan-Ting","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4562-6002","authenticated-orcid":false,"given":"Shu-Wei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1715-2495","authenticated-orcid":false,"given":"Chia-Jui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1832-8509","authenticated-orcid":false,"given":"Hsiu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5145-9538","authenticated-orcid":false,"given":"Wen-Ming","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3598-7218","authenticated-orcid":false,"given":"Yung-Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-5187","authenticated-orcid":false,"given":"Steven Shinn-Forng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9359-0606","authenticated-orcid":false,"given":"Mei-Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"7399_CR1","doi-asserted-by":"publisher","first-page":"102964","DOI":"10.1016\/j.eclinm.2024.102964","volume":"79","author":"J Nong","year":"2025","unstructured":"Nong J, Su C, Li C, Wang C, Li W, Li Y, et al. Global, regional, and National epidemiology of childhood neuroblastoma (1990\u20132021): a statistical analysis of incidence, mortality, and dalys. EClinicalMedicine. 2025;79:102964. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102964.","journal-title":"EClinicalMedicine"},{"key":"7399_CR2","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1200\/JCO.21.00278","volume":"39","author":"MS Irwin","year":"2021","unstructured":"Irwin MS, Naranjo A, Zhang FF, Cohn SL, London WB, Gastier-Foster JM, et al. Revised neuroblastoma risk classification system: A report from the children\u2019s oncology group. J Clin Oncol. 2021;39:3229\u201341. https:\/\/doi.org\/10.1200\/JCO.21.00278.","journal-title":"J Clin Oncol"},{"key":"7399_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11912-009-0059-6","volume":"11","author":"S Mueller","year":"2009","unstructured":"Mueller S, Matthay KK. Neuroblastoma: biology and staging. Curr Oncol Rep. 2009;11:431\u20138. https:\/\/doi.org\/10.1007\/s11912-009-0059-6.","journal-title":"Curr Oncol Rep"},{"key":"7399_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2967\/jnumed.112.102772","volume":"54","author":"MY Lu","year":"2013","unstructured":"Lu MY, Liu YL, Chang HH, Jou ST, Yang YL, Lin KH, et al. Characterization of neuroblastic tumors using 18F-FDOPA PET. J Nucl Med. 2013;54:42\u20139. https:\/\/doi.org\/10.2967\/jnumed.112.102772.","journal-title":"J Nucl Med"},{"key":"7399_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/RLU.0000000000003972","volume":"47","author":"KY Ko","year":"2022","unstructured":"Ko KY, Yen RF, Ko CL, Chou SW, Chang HH, Yang YL, et al. Prognostic value of interim 18F-DOPA and 18F-FDG PET\/CT findings in stage 3\u20134 pediatric neuroblastoma. Clin Nucl Med. 2022;47:21\u20135. https:\/\/doi.org\/10.1097\/RLU.0000000000003972.","journal-title":"Clin Nucl Med"},{"key":"7399_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00259-011-1938-2","volume":"39","author":"A Piccardo","year":"2012","unstructured":"Piccardo A, Lopci E, Conte M, Garaventa A, Foppiani L, Altrinetti V, et al. Comparison of 18F-dopa PET\/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study. Eur J Nucl Med Mol Imaging. 2012;39:57\u201371. https:\/\/doi.org\/10.1007\/s00259-011-1938-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7399_CR7","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1016\/j.ejrad.2015.09.027","volume":"84","author":"JW Lee","year":"2015","unstructured":"Lee JW, Cho A, Yun M, Lee JD, Lyu CJ, Kang WJ. Prognostic value of pretreatment FDG PET in pediatric neuroblastoma. Eur J Radiol. 2015;84:2633\u20139. https:\/\/doi.org\/10.1016\/j.ejrad.2015.09.027.","journal-title":"Eur J Radiol"},{"key":"7399_CR8","doi-asserted-by":"publisher","first-page":"1208531","DOI":"10.3389\/fonc.2023.1208531","volume":"13","author":"R Hu","year":"2023","unstructured":"Hu R, Zhang Y, Liu S, Lee P, Liu C, Liu A. Prognostic prediction by (18)F-FDG-PET\/CT parameters in patients with neuroblastoma: a systematic review and meta-analysis. Front Oncol. 2023;13:1208531. https:\/\/doi.org\/10.3389\/fonc.2023.1208531.","journal-title":"Front Oncol"},{"key":"7399_CR9","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1097\/RLU.0000000000001529","volume":"42","author":"CJ Liu","year":"2017","unstructured":"Liu CJ, Lu MY, Liu YL, Ko CL, Ko KY, Tzen KY, et al. Risk stratification of pediatric patients with neuroblastoma using volumetric parameters of 18F-FDG and 18F-DOPA PET\/CT. Clin Nucl Med. 2017;42:e142\u20138. https:\/\/doi.org\/10.1097\/RLU.0000000000001529.","journal-title":"Clin Nucl Med"},{"key":"7399_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.cpet.2014.03.008","volume":"9","author":"V Ambrosini","year":"2014","unstructured":"Ambrosini V, Nanni C, Fanti S. The use of gallium-68 labeled somatostatin receptors in PET\/CT imaging. PET Clin. 2014;9:323\u20139. https:\/\/doi.org\/10.1016\/j.cpet.2014.03.008.","journal-title":"PET Clin"},{"key":"7399_CR11","doi-asserted-by":"publisher","unstructured":"Stueven AK, Kayser A, Wetz C, Amthauer H, Wree A, Tacke F, et al. Somatostatin analogues in the treatment of neuroendocrine tumors: past, present and future. Int J Mol Sci. 2019;20. https:\/\/doi.org\/10.3390\/ijms20123049.","DOI":"10.3390\/ijms20123049"},{"key":"7399_CR12","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/s0959-8049(97)00212-8","volume":"33","author":"P Kogner","year":"1997","unstructured":"Kogner P, Borgstrom P, Bjellerup P, Schilling FH, Refai E, Jonsson C, et al. Somatostatin in neuroblastoma and ganglioneuroma. Eur J Cancer. 1997;33:2084\u20139. https:\/\/doi.org\/10.1016\/s0959-8049(97)00212-8.","journal-title":"Eur J Cancer"},{"key":"7399_CR13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ajcp\/102.6.752","volume":"102","author":"CL Moertel","year":"1994","unstructured":"Moertel CL, Reubi JC, Scheithauer BS, Schaid DJ, Kvols LK. Expression of somatostatin receptors in childhood neuroblastoma. Am J Clin Pathol. 1994;102:752\u20136. https:\/\/doi.org\/10.1093\/ajcp\/102.6.752.","journal-title":"Am J Clin Pathol"},{"key":"7399_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/MPH.0000000000001326","volume":"41","author":"N Alexander","year":"2019","unstructured":"Alexander N, Marrano P, Thorner P, Naranjo A, Van Ryn C, Martinez D, et al. Prevalence and clinical correlations of somatostatin Receptor-2 (SSTR2) expression in neuroblastoma. J Pediatr Hematol Oncol. 2019;41:222\u20137. https:\/\/doi.org\/10.1097\/MPH.0000000000001326.","journal-title":"J Pediatr Hematol Oncol"},{"key":"7399_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0167-0115(99)00121-4","volume":"88","author":"AR Albers","year":"2000","unstructured":"Albers AR, O\u2019Dorisio MS, Balster DA, Caprara M, Gosh P, Chen F, et al. Somatostatin receptor gene expression in neuroblastoma. Regul Pept. 2000;88:61\u201373. https:\/\/doi.org\/10.1016\/s0167-0115(99)00121-4.","journal-title":"Regul Pept"},{"key":"7399_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1267\/ahc.14024","volume":"47","author":"N Watanabe","year":"2014","unstructured":"Watanabe N, Nakanishi Y, Kinukawa N, Ohni S, Obana Y, Nakazawa A, et al. Expressions of somatostatin receptor subtypes (SSTR-1, 2, 3, 4 and 5) in neuroblastic tumors; special reference to clinicopathological correlations with international neuroblastoma pathology classification and outcomes. Acta Histochem Cytochem. 2014;47:219\u201329. https:\/\/doi.org\/10.1267\/ahc.14024.","journal-title":"Acta Histochem Cytochem"},{"key":"7399_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1053\/j.semnuclmed.2024.07.001","volume":"54","author":"AK Nazar","year":"2024","unstructured":"Nazar AK, Basu S. Radiolabeled somatostatin analogs for Cancer imaging. Semin Nucl Med. 2024;54:914\u201340. https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.07.001.","journal-title":"Semin Nucl Med"},{"key":"7399_CR18","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1210\/jcem.85.10.6904","volume":"85","author":"CC Raggi","year":"2000","unstructured":"Raggi CC, Maggi M, Renzi D, Calabro A, Bagnoni ML, Scaruffi P, et al. Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome. J Clin Endocrinol Metab. 2000;85:3866\u201373. https:\/\/doi.org\/10.1210\/jcem.85.10.6904.","journal-title":"J Clin Endocrinol Metab"},{"key":"7399_CR19","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2967\/jnumed.118.223016","volume":"60","author":"TA Hope","year":"2019","unstructured":"Hope TA, Calais J, Zhang L, Dieckmann W, Millo C. (111)In-Pentetreotide scintigraphy versus (68)Ga-DOTATATE PET: impact on Krenning scores and effect of tumor burden. J Nucl Med. 2019;60:1266\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.223016.","journal-title":"J Nucl Med"},{"key":"7399_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s13139-022-00762-6","volume":"56","author":"A Hemrom","year":"2022","unstructured":"Hemrom A, Arora G, Damle NA, Bal C. Comparative role of (18)F-DOPA PET\/CT and (131)I-MIBG scintigraphy in neuroblastoma and application of curie and SIOPEN scoring systems in (18)F-DOPA PET\/CT. Nucl Med Mol Imaging. 2022;56:236\u201344. https:\/\/doi.org\/10.1007\/s13139-022-00762-6.","journal-title":"Nucl Med Mol Imaging"},{"key":"7399_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cpet.2020.03.003","volume":"15","author":"Z Wen","year":"2020","unstructured":"Wen Z, Zhang L, Zhuang H. Roles of pet\/computed tomography in the evaluation of neuroblastoma. PET Clin. 2020;15:321\u201331. https:\/\/doi.org\/10.1016\/j.cpet.2020.03.003.","journal-title":"PET Clin"},{"key":"7399_CR22","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1210\/jc.2009-2604","volume":"95","author":"AF Jacobson","year":"2010","unstructured":"Jacobson AF, Deng H, Lombard J, Lessig HJ, Black RR. 123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab. 2010;95:2596\u2013606. https:\/\/doi.org\/10.1210\/jc.2009-2604.","journal-title":"J Clin Endocrinol Metab"},{"key":"7399_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2967\/jnumed.119.232553","volume":"61","author":"A Piccardo","year":"2020","unstructured":"Piccardo A, Morana G, Puntoni M, Campora S, Sorrentino S, Zucchetta P, et al. Diagnosis, treatment response, and prognosis: the role of (18)F-DOPA PET\/CT in children affected by neuroblastoma in comparison with (123)I-mIBG scan: the first prospective study. J Nucl Med. 2020;61:367\u201374. https:\/\/doi.org\/10.2967\/jnumed.119.232553.","journal-title":"J Nucl Med"},{"key":"7399_CR24","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1007\/s00259-020-04741-x","volume":"47","author":"JE Gains","year":"2020","unstructured":"Gains JE, Moroz V, Aldridge MD, Wan S, Wheatley K, Laidler J, et al. A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma. Eur J Nucl Med Mol Imaging. 2020;47:2348\u201357. https:\/\/doi.org\/10.1007\/s00259-020-04741-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7399_CR25","doi-asserted-by":"publisher","first-page":"836230","DOI":"10.3389\/fped.2022.836230","volume":"10","author":"F Sundquist","year":"2022","unstructured":"Sundquist F, Georgantzi K, Jarvis KB, Brok J, Koskenvuo M, Rascon J, et al. A phase II trial of a personalized, Dose-Intense administration schedule of (177)Lutetium-DOTATATE in children with primary refractory or relapsed High-Risk Neuroblastoma-LuDO-N. Front Pediatr. 2022;10:836230. https:\/\/doi.org\/10.3389\/fped.2022.836230.","journal-title":"Front Pediatr"},{"key":"7399_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00259-016-3486-2","volume":"44","author":"P Brunner","year":"2017","unstructured":"Brunner P, Jorg AC, Glatz K, Bubendorf L, Radojewski P, Umlauft M, et al. The prognostic and predictive value of sstr(2)-immunohistochemistry and sstr(2)-targeted imaging in neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2017;44:468\u201375. https:\/\/doi.org\/10.1007\/s00259-016-3486-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7399_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000005818","author":"X Wang","year":"2025","unstructured":"Wang X, Li S, Liu J, Yang J. Pseudoprogression on 68Ga-DOTATATE PET\/CT in a pediatric patient with neuroblastoma. Clin Nucl Med. 2025. https:\/\/doi.org\/10.1097\/RLU.0000000000005818.","journal-title":"Clin Nucl Med"},{"key":"7399_CR28","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1148\/rg.352140164","volume":"35","author":"MS Hofman","year":"2015","unstructured":"Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35:500\u201316. https:\/\/doi.org\/10.1148\/rg.352140164.","journal-title":"Radiographics"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07399-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:06:13Z","timestamp":1764219973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07399-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7399"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07399-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was granted by the Ethics Committee of National Taiwan University Hospital (IRB No.:202112156MIND) in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained through written documentation and signed by the legal guardians of underage participants. All data were anonymized to protect participant confidentiality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The requirement for informed consent to publish individual data or case details was waived by the Institutional Review Board due to no more than minimal risk to the participants, as all data has been anonymized and no identifiable information is included.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}